WhatsApp
backNews Article

India Glycols Posts Rs 15.25 Crores Profit Before Tax for Q2 on Rs 358.51 Crores Revenue After Demerger

Standalone financial results for quarter and half year ended Sept 30, 2026 reflect demerger impact with Spirits and Biofuel businesses now separate entities

India Glycols Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September 2026, reporting a Rs 15.25 crores profit before tax for Q2 and total revenue of Rs 358.51 crores. The results reflect the impact of the April 2026 demerger of Spirits, Biofuel and Biopharma undertakings, now operated by separate entities.

6 days ago|INDIAGLYCO-1.81%
India Glycols Limited500201INDIAGLYCOFinancial Results

India Glycols Limited

Financial Results

India Glycols Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September 2026, reporting a profit before tax of Rs 15.25 crores for Q2 on total income of Rs 358.51 crores. The company’s results reflect the demerger effective April 1, 2026, which transferred Spirits, Biofuel and Biopharma undertakings to separate entities.

The Board of Directors approved the unaudited standalone results on 13th November 2026 with the statutory auditors carrying out a limited review.

Total revenue from operations for Q2 was Rs 358.18 crores with total income including other income at Rs 358.51 crores. Expenses totalled Rs 343.26 crores, leading to an earnings before interest, depreciation, and tax (EBIDTA) of Rs 39.34 crores.

Profit before tax for the quarter stood at Rs 15.25 crores while the profit after tax was Rs 11.24 crores.

The half year ended 30th September 2026 recorded a profit before tax of Rs 31.79 crores on total income of Rs 713.52 crores.

The results exclude financial performance of the Spirits, Biofuel and Biopharma businesses due to their demerger into separate companies effective April 1, 2026, as approved by the National Company Law Tribunal on 17th July 2026.

Highlights

  • Quarterly revenue from operations was Rs 358.18 crores for Q2 FY2026-27.
  • Profit before tax for Q2 was Rs 15.25 crores; profit after tax was Rs 11.24 crores.
  • Half year ended 30th Sept 2026 profit before tax was Rs 31.79 crores.
  • Demerger of Spirits, Biofuel, and Biopharma businesses effective 1st April 2026 separated these undertakings into IGL Spirits Ltd and Ennature Bio Pharma Ltd.
  • Comparison figures for prior periods include the demerged businesses and are not directly comparable.

Key Data Snapshot

Quarter ended30th September 2026
Total income (Standalone)Rs 358.51 crores
Revenue from operations (Standalone)Rs 358.18 crores
Profit before tax (Q2)Rs 15.25 crores
Profit after tax (Q2)Rs 11.24 crores
Half year ended 30.09.2026 profit before taxRs 31.79 crores
Paid-up Equity Share CapitalRs 33.51 crores
Demerger effective date1st April 2026
Approval of Scheme of Arrangement by NCLT17th July 2026

What happened

  • India Glycols Limited announced its unaudited standalone financial results for quarter and half year ended 30th September 2026.
  • The Board approved the results on 13th November 2026 with limited review by auditors.
  • Reported profit before tax for Q2 was Rs 15.25 crores on revenue from operations of Rs 358.18 crores.

Key details

  • Revenue from operations was Rs 358.18 crores for Q2 and Rs 712.82 crores for the half year.
  • Profit after tax for Q2 was Rs 11.24 crores and for the half year was Rs 23.59 crores.
  • Demerger of Spirits, Biofuel, and Biopharma Undertakings effective 1st April 2026 transferred these operations to IGL Spirits Ltd and Ennature Bio Pharma Ltd.
  • Comparison with prior periods is limited as earlier results included the demerged undertakings.
  • Total expenses for the quarter were Rs 343.26 crores.

Regulatory and governance context

  • The Scheme of Arrangement was approved by the National Company Law Tribunal, Allahabad Bench on 17th July 2026.
  • The demerger became effective on 1st September 2026 with appointed date of 1st April 2026.
  • All carrying values of assets, liabilities and identified reserves of the demerged undertakings have been transferred to the respective resulting companies.
  • The difference in the carrying values was adjusted in other equity of India Glycols Limited.

Background and context

  • The company’s businesses are identified as a single reportable segment: Bio-based Specialities and Performance Chemicals after the demerger.
  • The Spirits and Biofuel and Biopharma businesses were significant in prior periods but have now demerged to separate companies.
  • Financial results for current periods exclude the demerged undertakings, while comparative figures include them, making direct comparisons not meaningful.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

View all news
India Glycols Posts Rs 15.25 Crores Profit Before Tax | Stockk News